Background: Sensitization patterns to dust mites depend on the geographic area and are important in clinical practice. However, the role of molecular diagnosis is not currently defined. We sought to characterize a pediatric population focusing on sensitization to different mite species and major mite components, to assess the clinical relevance of sensitization to allergenic components in our practice.
Introduction
Dust mites are the leading cause of respiratory allergy worldwide [1, 2] . However, sensitization patterns to house dust mites (HDM) and storage mites (SM) vary depending on the geographic area [3] [4] [5] [6] [7] [8] . In children, HDM are the earliest respiratory cause of sensitization [2] .
More than 30 allergens of Dermatophagoides pteronyssinus have been identified and sequenced until now [9] . Traditionally the "major'' allergens are Der p 1 and Der p 2 [7] [8] [9] [10] . However, Der p 23 has recently been identified as another HDM major allergen [11] .
Nonetheless little is currently known about its role in sensitization and its clinical relevance [12] [13] [14] [15] [16] [17] [18] .
The efficacy of immunotherapy in patients sensitized to the major allergens of group 1 and 2 has been thoroughly demonstrated. However, in patients sensitized to other allergens, such as Der p 23 the indication and efficacy of immunotherapy warrants further studies [4, 11, 15] . Overall, molecular diagnosis may play a role in mite allergy [14] [15] [16] [17] [18] , but its exact utility in clinical practice has not been fully defined yet.
We sought to characterize a pediatric Mediterranean population, focusing on the prevalence of sensitization to different mite species (both HDM and SM) and major components Der p 1, Der p 2 and Der p 23. Furthermore, we sought to assess the clinical relevance of sensitization to Der p 23 and the usefulness of commercially available allergenic components in the diagnostic work-up of mite allergy.
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Methods

Study population and study design
Consecutive children (3-18 for Asthma) and ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines [19, 20] .
Pharmacologic treatment and allergen-specific immunotherapy was prescribed following the personal medical criteria of each specialist in charge of the patient, in the event that clinical criteria were fulfilled.
Individuals under treatment with allergen-specific immunotherapy before the study began were excluded. All subjects that were under treatment were followed for a least three years as regular clinical practice.
We considered patients without clinical response to immunotherapy those patients with uncontrolled asthma according to GINA guideline: daytime symptoms, nocturnal waking due to asthma, rescue medication needed for symptoms relief and any activity limitation, after at least 3 years of treatment with immunotherapy and pharmacological treatment at the highest steps of the guideline.
Skin Prick Test
All patients were SPT with biologically standardized extracts including DP, DF and Euroglyphus maynei (100 HEP/mL), cypress pollen, olive tree pollen, grass mix pollen, Alternaria, cat and dog epithelium (30 HEP/mL), and with a battery of standardized extracts of SM, including Acarus siro, Chortoglyphus arcuatus, Glycyphagus domesticus, Lepidoglyphus destructor, Tyrophagus putrescentiae (all 30 HEP/mL), and Blomia tropicalis (100 HEP/mL). Patients were also tested with purified tropomyosin from shrimp extract (50 µg/mL) [21] .
All the SPT extracts were from LETI SL and were performed following EAACI guidelines [22] . A positive response was defined as the presence of a wheal with diameter ≥3 mm.
Histamine chloride 10 mg/mL was used as positive control.
Serum Specific IgE
Serum specific IgE (sIgE) to nDer p 1, rDer p 2, rDer p 10, was determined in all patients The study was approved by hospital ethics committee and signed informed consent was obtained from all patients (PIC-108-12).
Statistical analysis
Normal distribution of variables was investigated using the Komolgonov-Smirnov test.
Variables with normal and asymmetric distribution were expressed as mean ± standard deviation (SD) and as median (interquartile range 25%-75%; IQ) respectively.
Categoric variables were expressed as percentages and analyzed using the Chi-square test.
Spearman's correlation was used to identify linear relationships between the techniques used for molecular diagnosis. Differences were considered statistically significant if P<0.05. Statistical analysis was performed using the IBM SPSS statistical software package (v.18).
Results
Two hundred and seventy-six children who met the inclusion criteria of respiratory allergy and sensitization to DF and/or DP by SPT were prospectively and consecutively recruited.
Sixty-nine percent of these patients were exclusively sensitized to HDM. Clinical characteristics of the patients are summarized in table 1.
Sensitization profile
Sensitization to mite extracts by Skin pricks tests and prevalence of sensitization to mite's allergens by in vitro tests is summarized in tables 2 and 3, respectively. By ImmunoCAP, 90.6% (250/276) of patients were found to be sensitized to either nDer p1 and/or rDer p 2. Sensitization to rDer p 23 was 75.8% (201/265). Of these 265 patients, 5.3% (n=14) were sensitized to rDer p 23, but not to nDer p 1 or rDer p 2, without present-J Investig Allergol Clin Immunol 2020; Vol. 30 (2) © 2019 Esmon Publicidad doi: 10.18176/jiaci.0431 ing a different clinical phenotype compared to those sensitized also to Der p 1 and / or Der p 2 (table 4) .
The prevalence of sensitization to Der p 1, Der p 2 and Der p 23 increased with age ( figure   1 ).
A correlation between sIgE detected by ImmunoCAP and microarray for values of sIgE for Der p 1 (r=0.87; p<0.0001), for Der p 2 (r=0.87; p<0.0001) and for Der p 10 (r=0.88; p<0.0001) was observed, (figure 2).
Sensitizations and clinical implications
Major allergens were more often recognized by asthmatics patients. The prevalence of sensitization by ImmunoCAP to individual HDM allergens nDer p 1 (88.8% vs 75.5%), rDer p 2 (83.3% vs 70.5%) and rDer p 23 (79% vs 67%) differed significantly between children with and without asthma (P=0.003, P=0.01 and P=0.02, respectively).
Furthermore, patients with moderate and severe persistent asthma according to GINA criteria were more frequently sensitized to Der p 23 than patients with intermittent and mild persistent forms of asthma (75.8% vs 90%, P=0.008). Among those patients completing ITE for 3 years, 11 did not show a clinical response to allergen-specific immunotherapy, since they maintained uncontrolled asthma. All of them were sensitized to Der p 23 (table   5) .
Considering those patients sensitized to Der p 23 but not to Der p 1 and Der p 2 (n=14), only 3 had been prescribed immunotherapy, even though 50% had asthma and 71.4% per-J Investig Allergol Clin Immunol 2020; Vol. 30 (2) © 2019 Esmon Publicidad doi: 10.18176/jiaci.0431 sistent rhinitis. Of these three patients, two did not respond to treatment after 3 years (table   4) .
Comparison between SPT and molecular diagnosis
All patients with sensitization to Der p 1 or Der p 2 had a positive SPT to DP and 97% had a positive SPT to DF. Likewise, all patients with selective sensitization to rDer p 23 had a positive SPT to DP while only 50% had a positive SPT to DF (P<0.002).
Sensitization to tropomyosin by ImmunoCAP was higher than by SPT (9.8% vs 6.5%).
SPT for tropomyosin was positive for the two patients who had a positive specific IgE to rDer p 10 without sensitization to nDer p 1, rDer p 2 and rDer p 23.
Sensitization to Lepidoglyphus and Blomia significantly differed when detected by SPT versus microarray (47.8% vs 23.2% and 30.8% vs 15.6%, respectively; P=0.03, P=0.02).
All patients sensitized to Blomia by SPT were also sensitized to major components of Dermatophagoides. Regarding patients sensitized to Lepidoglyphus, only one patient had reactivity to rLep d 2 without sensitization to Der p 1, Der p 2, and Der p 23.
Discussion
This study describes the sensitization profile to different HDM and SM species as sensitization to major allergens of a pediatric population with respiratory allergy disease. Moreover, it illustrates the clinical relevance of sensitization to Der p 23. For the first time in children, sensitization to Der p 23 has been linked to persistent moderate/severe asthma.
To date, the diagnostic value of molecular diagnosis complementing SPT has not been fully J Investig Allergol Clin Immunol 2020; Vol. 30 (2) © 2019 Esmon Publicidad doi: 10.18176/jiaci.0431 established. Our study proposes criteria for the real-life use of molecular diagnosis in patients with respiratory allergy and positive SPT to mites. As expected, Der p 1 and/or Der p 2 were recognized by most of the patients (90.6%), and Der p 23, recently identified as a HDM major allergen [7, 8, 11, 12, 13, 14, 15, 18, 23, 24, 25] , was recognized by 75.8% of HDM allergic patients, similar to other Mediterranean series [10, 12, 13, 14, 24, 26] . Remarkably, in 9.4% of our patients, no sensitization to the major allergens Der p 1 and Der p 2 was detected. It is important to note that 56% of these patients were sensitized to Der p 23.
Interestingly, sensitization to group 1 was more prevalent than to group 2 major allergens.
In our patients, prevalence of asthma was almost 70% (63% persistent asthma), and Der p 1 has been related to the development and severity of asthma in childhood [20, 23] .
Our study shows a greater recognition of Der p 1, Der p 2 and Der p 23 in asthmatic patients compared to rhinitis, which agrees with other investigations [9, 11, 13, 15 ]. An important finding in our work was the significantly higher recognition of Der p 23 in patients with persistent moderate/severe asthma.
Furthermore, most patients with sensitization to Der p 23, but not to Der p 1 and Der p 2, had not received immunotherapy even when they could have potentially benefited from this.
Moreover, the eleven patients that did not respond to immunotherapy were all sensitized to In our study, tropomyosin sensitization was 9.8%, similar to another study with children from a Mediterranean area [20] . As expected, most children sensitized to Der p 10 were J Investig Allergol Clin Immunol 2020; Vol. 30 (2) © 2019 Esmon Publicidad doi: 10.18176/jiaci.0431 also sensitized to major allergens tested. Only two (0.7%) had a sensitization to Der p 10 without sensitization to Der p1, Der p 2 and Der p 23, which confirms that Der p 10 represents a minor allergen in respiratory allergy to mites [19] [20] [21] [22] . These children had a positive SPT to tropomyosin. Thus, the inclusion of purified shrimp tropomyosin in the diagnostic panel of respiratory allergy could be relevant. Moreover, Resch et al [10] recently concluded that Der p 10-positive patients reacted to other mite allergens rDer p 5, rDer p 7 and rDer p 21. Therefore, these patients with SPT to tropomyosin positive could be interesting candidates for further molecular diagnosis.
Finally, in our study we observed a high sensitization rate to SM allergens; a limitation of our study was to study SM sensitization in patients selected based on positive SPT to HDM. We therefore missed those patients of selectively sensitization to SM, although in our area exclusive SM sensitization has been previously described as low (0.8%) [6] .
Lepidoglyphus, was considered the predominant SM species in Europe, followed by Blomia. Prevalence of sensitization to Lep d 2 and Blo t 5 was lower than sensitization detected with the corresponding extracts by SPT. This discrepancy may indicate sensitization to other components, not represented in the molecular diagnosis platform used. Therefore, determination of sensitization to both the whole extract and the major allergens Lep d 2 and Blo t 5 prior prescription of allergen specific immunotherapy to SM is important.
It is also remarkable that all children sensitized to Lepidoglyphus, except one, and all sensitized to Blomia were also sensitized to the major allergens of DP and DF. This is in accordance with previous works [4, 25] that defend that sensitization to SM is related to HDM exposure.
In conclusion, this study confirms the importance of molecular components in aiding further diagnosis in mite allergic patients. We provide evidence for the importance of major 
